Please ensure Javascript is enabled for purposes of website accessibility

Court Partially Overturns Class-Action Lawsuit Against OrganiGram Holdings

By Eric Volkman - May 1, 2020 at 1:56PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The legal action against the cannabis company will continue, but its scope has been considerably reduced.

OrganiGram Holdings (OGI -3.51%) announced Thursday that a class-action lawsuit against it has been partially overturned. A ruling by the Nova Scotia Court of Appeal has the effect of "significantly reducing the scope of the claim against the Company," in OrganiGram's words.

In 2018, Dawn Rae Downton sued OrganiGram for supplying her with medical cannabis that allegedly contained unauthorized pesticides and made her ill. Early the next year, her action was widened into a class-action lawsuit involving other OrganiGram customers.

Gavel with marijuana leaf.

Image source: Getty Images.

According to OrganiGram, the appeals court ruled that the plaintiffs did not present any evidence that the cannabis in question had caused any harmful health effects. On that basis, the class members will not be able to seek damages related to such effects.

The lawsuit will continue, albeit only seeking compensation for the money that customers spent on the cannabis in question. The batches in question were purchased by patients in 2016. Subsequent to that, OrganiGram recalled the affected product, and the marijuana company says it has already reimbursed many of the customers who bought the allegedly tainted cannabis.

OrganiGram added that its insurance provider has appointed a lawyer to represent the company in the class-action suit. That insurer might cover at least some of the fees and damages OrganiGram could have to pay. 

"Organigram management does not anticipate that what remains of the class action (including the resolution thereof) will affect its business or operations in any material way," the company said in its press release updating the case.

On Thursday, OrganiGram's stock fell by nearly 3.1%, exceeding the decline of the wider equities market.

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends OrganiGram Holdings. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

OrganiGram Holdings Stock Quote
OrganiGram Holdings
$1.10 (-3.51%) $0.04

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/19/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.